Φορτώνει......
Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell function
BACKGROUND AIMS. Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 has demonstrated remarkable success in targeting B-cell malignancies but is often complicated by serious systemic toxicity in the form of cytokine release syndrome (CRS). CRS symptoms are primarily mediated by interleukin...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cytotherapy |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6676485/ https://ncbi.nlm.nih.gov/pubmed/28506444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2017.04.001 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|